SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 100 filers reported holding SURFACE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $20 | -77.3% | 29,251 | -72.7% | 0.00% | – |
Q4 2022 | $88 | -100.0% | 107,317 | -74.3% | 0.00% | – |
Q3 2022 | $434,000 | -38.6% | 417,765 | -3.0% | 0.00% | – |
Q2 2022 | $707,000 | +128.1% | 430,808 | +309.8% | 0.00% | – |
Q1 2022 | $310,000 | -47.5% | 105,119 | -14.7% | 0.00% | – |
Q4 2021 | $590,000 | +212.2% | 123,270 | +396.3% | 0.00% | – |
Q3 2021 | $189,000 | -57.4% | 24,838 | -58.3% | 0.00% | – |
Q2 2021 | $444,000 | -38.6% | 59,506 | -35.8% | 0.00% | – |
Q1 2021 | $723,000 | +72200.0% | 92,648 | +107630.2% | 0.00% | – |
Q4 2020 | $1,000 | -98.5% | 86 | -99.2% | 0.00% | – |
Q2 2020 | $68,000 | +78.9% | 10,388 | -48.9% | 0.00% | – |
Q4 2019 | $38,000 | +26.7% | 20,317 | -3.7% | 0.00% | – |
Q3 2019 | $30,000 | -57.7% | 21,101 | -17.1% | 0.00% | – |
Q2 2019 | $71,000 | +343.8% | 25,455 | +628.3% | 0.00% | – |
Q1 2019 | $16,000 | -46.7% | 3,495 | +28.3% | 0.00% | – |
Q3 2018 | $30,000 | +233.3% | 2,724 | +412.0% | 0.00% | – |
Q2 2018 | $9,000 | – | 532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |